Dynamic oversight: Implementation gaps and challenges

Journal of Nanoparticle Research

Volumn 13, Issue 4, 2011, Pages 1427-1434

  Howard, John ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Benzene; Governance; Hard law approaches; International standards; Nanobiotechnology; Nanotoxicology; National Technology Transfer and Advancement Act; Occupational Safety and Health Act; Occupational safety and health standard; REACH; Soft law approaches

Indexed keywords

GOVERNANCE; HARD LAW APPROACHES; INTERNATIONAL STANDARDS; NANOTOXICOLOGY; NATIONAL TECHNOLOGY TRANSFER AND ADVANCEMENT ACT; OCCUPATIONAL SAFETY AND HEALTH ACTS; OCCUPATIONAL SAFETY AND HEALTH STANDARDS; REACH; SOFT LAW APPROACHES;

BENZENE; CARBON NANOTUBES; DRUG THERAPY; HEALTH; HEALTH RISKS; INDUSTRIAL HYGIENE; NANOSTRUCTURES; STANDARDS; TECHNOLOGY TRANSFER;

OCCUPATIONAL RISKS;

CARBON NANOTUBE; METAL OXIDE; NANOMATERIAL;

COMPOSITE MATERIAL; GOVERNMENT REGULATION; HUMAN; LAW; NANOTECHNOLOGY; NANOTOXICOLOGY; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; PRIORITY JOURNAL; REVIEW; STANDARD; THERMAL CONDUCTIVITY; THERMAL EXPOSURE;

EID: 79956114513     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-011-0225-2     Document Type: Review

References (54)

1. Afonin KA, Bindewald E, Yaghoubian AJ, Voss N, Jacovetty E, Shapiro BA, Jaeger L (2010) In vitro assembly of cubic RNA-based scaffolds designed in silico. Nat Nanotechnol 5:676-682
2. American Federation of Labor-Congress of Industrial Organizations v. OSHA, 965 F.2d 962 (11th Cir. 1992)
3. Arnall AH (2003) Future technologies today's choices. Greenpeace Environmental Trust, London
4. Bell C, Marrapese M (2011) Nanotechnology standards and international legal considerations. In:Murashov V,Howard J (eds) Nanotechnology standards. Springer, New York
5. Choi JY, Ramachandran G (2009) Review of the OSHA framework for oversight of occupational environments. J Law Med Ethics 37:633-650
6. Choi JY, Ramachandran G, Kandlikar M (2009) The impact of toxicity testing costs on nanomaterial regulation. Environ Sci Technol 43:3030-3034
7. Collins PG, Avouris P (2000) Nanotubes for electronics. Sci Am 283:62-69
8. Davies CJ (2009) Oversight of next generation nanotechnology. Project on Emerging Technologies, Washington, DC. http://www.nanotechproject.org/process/ assets/files/7316/pen-18.pdf. Accessed 2 Oct 2010
9. European Union (E.U.) (2006) Regulation (EC) No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). Off J Eur Commun; L1363-280. http://www.reach- 21compliance.eu/english/ legislation/docs/launchers/ launch-2006-1907-EC.html. Accessed 2 Oct 2010
10. Han JH, Lee EJ, Lee JH, So KP, Lee YH, Bae GN, Lee SB, Ji JH, Cho MH, Yu IJ (2008) Monitoring multi-walled carbon nanotube exposure in carbon nanotube research facility. Inhal Tox 20:1-9
11. Hansen ST, Maynard A, Baun A et al (2008) Late lessons from early warnings about nanotechnology. Nat Nanotechnol 3:444-447
12. Harremoës P, Gee D, MacGavin M, Stirling A, Keys J, Wynne B, Guedes Vaz S (2001) Late lessons from early warnings: the precautionary principle 1896-2000. European environmental agency, Copenhagen. http://www.eea.europa.eu/ publications/ environmental-issue-report-2001-22. Accessed 2 Oct 2010
13. Haufler V (2010) Private sector and international standardsetting: the challenge for business and government. Carnegie discussion paper 3, Study Group on the role of the private sector. http://www.carnegieendowment.org/ publications/index.cfm?fa=view&id=220. Accessed 2 Oct 2010
14. Howard J, Murashov V (2009) National nanotechnology partnership to protect workers. J Nanopart Res 11:1673-1683
15. Industrial Union Department vs. American Petroleum Institute (1980) 44 U.S. 607
16. International Center for Technology Assessment (ICTA) (2008) Principles for the oversight of nanotechnologies and nanomaterials. International center for technology assessment, Washington, DC. http://www.icta.org/doc/ Principles%20for%20the%20Oversight%20of%20Nano technologies%20and%20Nanomaterials-final.pdf. Accessed 2 Oct 2010
17. International Risk Governance Council (IRCG) (2007) Policy brief: nanotechnology risk governance. International risk governance council, Geneva. http://www.irgc.org/IMG/ pdf/PB-nanoFINAL2-2-.pdf. Accessed 2 Oct 2010
18. Kuhlbusch TAJ, Fissan H (2006) Particle characteristics in the reactor and pelletizing areas of carbon black production. J Occup Environ Health 3:558-567 (Pubitemid 44266958)
19. Lin AC (2007) Size matters: regulating nanotechnology. Harvard Environ Law Rev 31:350-408
20. Lux Research (2007) The nanotech report: investment overview and market research for nanotechnology, 5th edn. Lux Research Inc., New York
21. Marchant GE, Sylvester DJ, Abbott KW (2009a) What does the history of technology regulation teach us about nano oversight? J Law Med Ethics 37:724-731
22. Marchant GE, Sylvester DJ, Abbott KW (2009b) A new soft law approach to nanotechnology oversight: a voluntary product certification scheme. UCLA J Environ Law Policy (forthcoming). http://papers.ssrn.com/sol3/papers.cfm? abstract-id=1483910 Accessed 2 Oct 2010
23. Maynard A (2009) Commentary: oversight of engineered nanomaterials in the workplace. J Law Med Ethics 37:651-658
24. McGarity TO (1992) Some thoughts on "deossifying" the rulemaking process. Duke Law J 41:1385-1462
25. McGarity T, Shapiro S (1993) Workers at risk: the failed promise of the occupational safety and health administration. Praeger, Westport
26. Methner MM, Birch ME, Evans DE, Ku BK, Crouch K, Hoover MD (2007) Case study: identification and characterization of potential sources of worker exposure to carbon nanofibers during polymer composite laboratory operations. J Occup Environ Hyg 4:D125-D130
27. Munich Re Group (2002)Nanotechnology:what is in store for us? Münchener. Rückversicherungs-Gesellschaft AG, Munich
28. Murashov V, Howard J (2008) The U.S. must help set international standards in nanotechnology. Nat Nanotechnol 3:635-636
29. Murashov V, Howard J (2009) Essential features for proactive risk management. J Nanopart Res 4:467-470
30. Murashov V, Howard J (2010) Nanotechnology standards. Springer (forthcoming)
31. National Institute for Standards and Technology (2008) Eleventh annual report on federal agency use of voluntary consensus standards and conformity assessment. https://standards.gov/ NTTAA/resources/nttaa-ar-2008.pdf. Accessed 2 Oct 2010
32. National Science Foundation (2006) Active Nanostructures and Nanosystems (ANN). Program solicitation NSF 06-595. http://www.nsf.gov/pubs/2006/nsf06595/ nsf06595.htm. Accessed 2 Oct 2010
33. National Technology Transfer and Advancement Act (1996) (P.L. 104-113) 15 U.S.C. § 4301. http://standards.gov/standards-gov/nttaa.cfm Accessed 2 October 2010
34. Oberdörster G, Oberdörster E, Oberdörster J (2007) Concepts of nanoparticle dose metric and response metric. Environ Health Perspect 115:A290
35. Occupational Safety and Health Act of 1970, 29 U.S.C. §§ 651-678:2000
36. Occupational Safety and Health Act of 1970, 29 U.S.C. § 652(8):2000
37. Occupational Safety and Health Act of 1970, 29 U.S.C. § 667:2000
38. Ogden T (2010) REACH - how is it going? Ann Occup Hyg 54:1-4
39. OSHA (1989) Air contaminants. Federal Register 54:2332-2983 (January 19, 1989). http://www.osha.gov/pls/oshaweb/owadisp. show-document?p-table=FEDERAL- REGISTER&p-id= 12908. Accessed 2 Oct 2010
40. Paradise J, Wolf SM, Kuzma J, Ramachandran G, Kokkoli E (2009a) Introduction: the challenge of developing oversight approaches to nanotechnology. J Law Med Ethics 37:543-545
41. Paradise J, Wolf SM, Kuzma J, Kuzhabekova A, Tisdale AW, Kokkoli E, Ramachandran G (2009b) Developing U.S. oversight strategies for nanobiotechnology: learning from past oversight experiences. J Law Med Ethics 37:688-705
42. Peters TM, Heitbrink WA, Evans DE, Slavin TJ, Maynard AD (2006) The mapping of fine and ultrafine particle concentrations in an engine machining and assembly facility. Ann Occup Hyg 50:1-9
43. Priest S, Greenbaugh T, Kramer V (2010) Risk perceptions starting to shift? U.S. citizens are forming opinions about nanotechnology. J Nanopart Res 12:11-20
44. Project on emerging nanotechnologies (PEN) (2010) consumer products inventory. http://www.nanotechproject.org/ inventories/consumer/. Accessed 2 Oct 2010
45. Schulte PA, Murashov V, Zumwalde R, Kuempel ED, Geraci CL (2010) Occupational exposure limits for nanomaterials: state of the art. J Nanopart Res 12:1971-1987
46. Shvedova AA, Kisin ER, Murray AR, Johnson VJ, Gorelik O, Arepalli S, Hubbs AF, Mercer RR, Keohavong P, Sussman N, Jin J, Yin J, Stone S, Chen BT, Deye G, Maynard A, Castranova V, Baron PA, Kagan VE (2008) Inhalation versus aspiration of single walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress and mutagenesis. Am J Physiol Lung Cell Mol Physiol 295:L552-L565
47. Shvedova AA, Kisin ER, Porter D, Schulte P, Kagan VE, Fadeel B, Castranova V (2009) Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: two faces of Janus? Pharm Ther 121:192-204
48. Subramanian V, Youtie J, Porter AL, Shapira P (2010) Is there a shift to "active nanostructures"? J Nanopart Res 12:1-10
49. Swiss Re (2004) Nanotechnology: smallmatter, many unknowns. http://www.asse.org/nanotechnology/pdfs/govupdate-02-3-05-nanosafety.pdf. Accessed 2 Oct 2010
50. Terrones M (2003) Science and technology of the 21st century: synthesis, properties, and applications of carbon nanotubes. Annu Rev Mater Res 33:419-501
51. Tsai SJC, Ashter A, Ada E, Mead JL, Barry CF, Ellenbecker MJ (2008) Airborne nanoparticle release associated with the compounding of nanocomposites using nanoalumina as fillers. Aerosol Air Qual Res 8:160-177
52. Vincent JH (1998) International occupational exposure standards: a review and commentary. AIHA J 59:729-742
53. Wang J, Chen C, Liu Y et al (2008) Potential neurological lesion after nasal instillation of TiO2 nanoparticles in the anatase and rutile crystal phases. Toxicol Lett 183:72-80
54. Wilson RF (2006) Nanotechnology: the challenge of regulating known unknowns. J Law Med Ethics 34:704-713